Skip to main content
Log in

Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog

  • Short Communication
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

On local injection into the innervated hindleg of the dog piribedil, like apomorphine, produced a vasodilatation blocked by haloperidol. S584, the catechol metabolite of piribedil, produced a vasodilatation which was not blocked by haloperidol. Neither propranolol nor atropine influenced the vasodilatation produced by piribedil or S584. Denervation of the hindleg abolished the responses to piribedil and S584. During the infusion of noradrenaline into the denervated hindleg, the responses to S584 reappeared but those to piribedil did not. It is concluded from these experiments that the vasodilatation produced by piribedil in the innervated hindleg of the dog, like that of apomorphine, is mediated by dopamine receptors and that the effect of piribedil cannot be explained by the formation of its catechol metabolite S584.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Buylaert, W. A., Willems, J. L., Bogaert, M. G.: Vasodilatation produced by apomorphine in the hindleg of the dog. J. Pharmacol. Exp. Ther., (in press, 1977)

  • Corrodi, H., Fuxe, K., Ungerstedt, U.: Evidence for a new type of dopamine receptor stimulating agent. J. Pharm. Pharmacol. 23, 989–991 (1971)

    Google Scholar 

  • Iversen, L. L., Horn, A. S., Miller, R. J.: Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates. Adv. Neurol. 9, 197–212 (1975)

    Google Scholar 

  • Laubie, M., Schmitt, H., Le Douarec, J. C.: Cardiovascular effects of the 1-(2″-pyrimidyl)-4-piperonyl piperazine (ET495). Eur. J. Pharmacol. 6, 75–82 (1969)

    Google Scholar 

  • Laubie, M., Schmitt, H., and Falq, E.: Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect. Eur. J. Pharmacol. 42, 307–310 (1977)

    Google Scholar 

  • Makman, M. H., Mishra, R. K., Brown, J. H.: Drug interactions with dopamine-stimulated adenylate cyclases of caudate nucleus and retina: direct agonist effect of a piribedil metabolite. Adv. Neurol. 9, 213–222 (1975)

    Google Scholar 

  • Regnier, G., Canevari, R., Laubie, M., Le Douarec, J. C.: Synthesis and vasodilator activity of new piperazine derivatives. J. Med. Chem. 11, 1151–1155 (1968)

    Google Scholar 

  • Willems, J. L.: Dopamine-induced inhibition of synaptic transmission in lumbar paravertebral ganglia of the dog. Naunyn-Schmiedeberg's Arch. Pharmacol. 279 115–126 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buylaert, W.A. Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 101–103 (1977). https://doi.org/10.1007/BF00508645

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00508645

Key words

Navigation